Exploration of prognostic biomarkers in head and neck squamous cell carcinoma microenvironment from TCGA database

BACKGROUND: Immune checkpoint blockade (ICB) therapies have redefined human cancer treatment, including for head and neck squamous cell carcinoma (HNSCC). However, clinical responses to various immune checkpoint inhibitors are often accompanied by immune-related adverse events (irAEs). Therefore, it...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ying, Bi, Jianping, Pi, Guoliang, He, Hanping, Li, Yanping, Han, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009575/
https://www.ncbi.nlm.nih.gov/pubmed/36923087
http://dx.doi.org/10.21037/atm-22-6481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009575/
https://www.ncbi.nlm.nih.gov/pubmed/36923087
http://dx.doi.org/10.21037/atm-22-6481

Ejemplares similares